Gidazepam | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 387.2 g/mol [1] |
Predicted LogP | 1.7 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C17H15BrN4O2 [1] |
IUPAC name | 2-(7-bromo-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl)acetohydrazide [1] |
SMILES | C1C(=O)N(C2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3)CC(=O)NN [1] |
InChI | InChI=1S/C17H15BrN4O2/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)20-9-16(24)22(14)10-15(23)21-19/h1-8H,9-10,19H2,(H,21,23) [1] |
InChIKey | XLGCMZLSEXRBSG-UHFFFAOYSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | ~87 hours |
Gidazepam
Gidazepam (also known as (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one, 2-(9-Bromo-3-oxo-6-phenyl-2,5-diazabicyclo(5.4.0) undeca-5,8,10,12-tetraen-2-yl) acetohydrazide, 1H-1,4-Benzodiazepine-1-acetic acid, 7-bromo-2,3-dihydro-2-oxo-5-phenyl-, hydrazide, 2-(7-bromo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl)acetohydrazide, Gidasepam;Hidazepam; Hydazepam, Mls001012266, Smr000425069, (7-Bromo-2-oxo-5-phenyl-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-acetic acid hydrazide, ChemDiv1_027291 or Oprea1_121006) is a
Chemistry
Stereochemistry []
Gidazepam is a achiral mixture
Legal status
- Canada: Gidazepam is a Schedule IV substance.
- United States: Gidazepam is a Unscheduled substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 121919, Gidazepam. Accessed July 3, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/121919
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Gidazepam. UNII: XMJ87I93Y9. Global Substance Registration System. Accessed July 3, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/XMJ87I93Y9